Renaissance Technologies
BDMD

Renaissance Technologies’s Baird Medical Investment Holdings BDMD Stock Holding History

Renaissance Technologies’s Portfolio BDMD Stock Details BDMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.7K Buy
+55,371
New +$86K ﹤0.01% 3024

Other funds holding BDMD

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Renaissance Technologies's BDMD Position: Q2 2026 in Review

Renaissance Technologies opened a new position in Baird Medical Investment Holdings (BDMD) in Q2 2026: 55,371 shares worth $63.7K. The stake represents ﹤0.01% of the portfolio and ranks #3024 among its holdings.

6 funds tracked by Wall St. Rank hold BDMD as of Q2 2026.

  • Renaissance Technologies held 55,371 shares of Baird Medical Investment Holdings worth $63.7K as of Q2 2026.
  • Baird Medical Investment Holdings was a new Renaissance Technologies position in Q2 2026.
  • Baird Medical Investment Holdings made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #3024 holding.
  • 6 funds tracked by Wall St. Rank held Baird Medical Investment Holdings as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.